Filing Details

Accession Number:
0001209191-15-052408
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-11 18:13:34
Reporting Period:
2015-06-09
Filing Date:
2015-06-11
Accepted Time:
2015-06-11 18:13:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208906 L John Higgins 11119 North Torrey Pines Road, Suite 200
La Jolla CA 92037
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-09 6,200 $92.53 129,844 No 4 S Direct
Common Stock Disposition 2015-06-09 3,300 $93.21 126,544 No 4 S Direct
Common Stock Disposition 2015-06-09 500 $95.06 126,044 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.96, inclusive. The reporting person undertakes to provide, upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.52, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.67 to $95.26, inclusive.